estrone has been researched along with Primary Ovarian Insufficiency in 4 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 9.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| "We conclude that estradiol pellets after a single administration provide constant estradiol levels extending into the first trimester of pregnancy, a physiologic estradiol:estrone ratio, and a better endometrial response than standard estrogen regimens." | 5.08 | Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. ( DeOrio, L; Dmowski, WP; Friberg, J; McGill-Johnson, E; Michalowska, J; Rana, N, 1997) |
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 5.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| "Four patients with premature ovarian failure were treated with either oral or transdermal patch estrogen replacement." | 1.29 | Protein S levels during the normal menstrual cycle and during estrogen therapy for premature ovarian failure. ( Carr, ME; Steingold, KA; Zekert, SL, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takemoto, M | 1 |
| Morishita, H | 1 |
| Higuchi, K | 1 |
| Yoshida, J | 1 |
| Aono, T | 1 |
| Carr, ME | 1 |
| Steingold, KA | 1 |
| Zekert, SL | 1 |
| Dmowski, WP | 1 |
| Michalowska, J | 1 |
| Rana, N | 1 |
| Friberg, J | 1 |
| McGill-Johnson, E | 1 |
| DeOrio, L | 1 |
| de Ziegler, D | 1 |
| Bergeron, C | 1 |
| Cornel, C | 1 |
| Medalie, DA | 1 |
| Massai, MR | 1 |
| Milgrom, E | 1 |
| Frydman, R | 1 |
| Bouchard, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00377923] | Phase 1 | 24 participants | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for estrone and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
Topics: Adult; Amenorrhea; Body Weight; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lu | 1994 |
Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response.
Topics: Abortion, Spontaneous; Adult; Embryo Implantation; Embryo Transfer; Endometrium; Estradiol; Estrone; | 1997 |
Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Biopsy; Corpus Luteum; Endometrium; | 1992 |
1 other study available for estrone and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Protein S levels during the normal menstrual cycle and during estrogen therapy for premature ovarian failure.
Topics: Adult; Aged; Carrier Proteins; Complement Inactivator Proteins; Estradiol; Estrogen Replacement Ther | 1993 |